Beijing Dayspring Pharmaceutical Technology Co., Ltd

This study tested a new medication called CG2001 for male pattern baldness in Chinese men aged 18 to 65. The goal was to see if it helps regrow hair and is safe to use. The trial involved 110 participants and measured changes in hair count after 24 weeks.